Add like
Add dislike
Add to saved papers

NIR/blue light emission optimization of NaY 1-(x+y) Yb x F 4 :Tm y upconversion nanoparticles via Yb 3+ /Tm 3+ dopant balancing.

The increased applications of lanthanide-doped upconversion nanoparticles (UCNPs) in areas such as biomedical imaging and therapy have raised the demand for high quality nanocrystals with strong and controllable luminescence intensity. Whilst several different approaches including core/shell arrangement, dye sensitization and plasmonic metallic nanostructures have been employed to improve the upconversion luminescence of UCNPs, they may be impractical for scale-up production and applications. Herein, a mathematical model that was developed using multivariate statistical analysis shows that the key to optimising the NIR and blue light emission of NaY1-(x+y)YbxF4:Tmy UCNPs is dopant balancing, where the composition of both ytterbium (Yb3+) sensitizer and thulium (Tm3+) activator is controlled in a way that the concentration and proximity of the dopants to each other can reduce cross-relaxation between Tm3+ and self-quenching that is due to sub-optimal Yb3+ concentrations, and consequently, favours efficient energy transfer between the Yb3+ sensitizers and Tm3+ activators. The data driven approach gives better understanding of the role of dopant balancing in the upconversion process and presents a general yet effective strategy to enhance the optical properties of UCNPs by manipulating the relative concentrations of the lanthanide dopants. This systematic approach will have important implications and it can be integrated with other emission enhancing strategies to produce high quality UCNPs for diverse applications in photonics, imaging, sensing, drug delivery and solar energy conversion.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app